You are using an older browser version. Please use a supported version for the best MSN experience.

Glenmark Life Sciences’ IPO | Core Strengths & Key Risks Explained

Glenmark’s API subsidiary Glenmark Life Sciences’ IPO process will commence this week. IPO DETAILS: Subscription: 27-29 July Price band: Rs 695-720 per shareTotal issue size: `1513.6 crUse of proceeds: - Payment of outstanding purchase consideration to Promoter for the spin-off of API business (from Promoter into their company) - Funding working capital requirements- General corporate purposes Ahead of the IPO, Moneycontrol's Karunya Rao fills us in on all the details to help you decide if you should subscribe to offer or not.#GlenmarkLifeSciences’IPOFollow us:Website: https://www.moneycontrol.com/Facebook: https://www.facebook.com/moneycontrol/Twitter: http://www.twitter.com/moneycontrolcomInstagram: https://www.instagram.com/moneycontrolcom/

UP NEXT

UP NEXT

image beaconimage beaconimage beacon